Latest News

Seat Elevators on Power Wheelchairs are a Necessity, not a Luxury, according to the SMA Community

September 13, 2022
Posted in , ,

Individuals with spinal muscular atrophy (SMA) who utilize power wheelchairs for their mobility agree that seat elevation, which allows an individual to adjust their wheelchair seat, helps improve mental and […]

Read More ›

Cure SMA Launches Benefit-Risk Survey to Assess Patient Perspective on Treatment Possibilities and Risks

September 8, 2022
Posted in , ,

Cure SMA is conducting a survey to understand our community’s perspectives on treatment possibilities and tolerance for the side effects of currently available and planned therapies. The results will help […]

Read More ›

Cure SMA Care Center Network Site Expansion

August 30, 2022
Posted in ,

The Cure SMA Care Center Network is excited to announce the addition of 9 NEW centers to the Care Center Network, bringing the current total number of participants in the […]

Read More ›

Community Statement from Novartis Gene Therapies: Zolgensma Safety Monitoring Update on Acute Liver Failure

August 29, 2022
Posted in ,

Dear SMA Community, Novartis Gene Therapies is committed to patient safety and the ongoing monitoring of adverse events as it relates to the use of Zolgensma® (onasemnogene abeparvovec-xioi), the one-time […]

Read More ›

Biogen Shares Community Statement for SMA Awareness Month

August 24, 2022
Posted in ,

Learn about Biogen’s latest news in SMA by viewing their Community Statement (available as a PDF) and a related video.

Read More ›

FDA Issues Safety Warning Regarding Neck Float Devices for Babies

August 18, 2022
Posted in

On June 28,2022, the U.S. Food and Drug Administration (FDA) issued a safety communication about using neck float with babies. This occurs when a serious injury has been reported while […]

Read More ›
Scroll to Top